Melville, New York-based Henry Schein, Inc. (HSIC) provides health care products and services to office-based dental and medical practitioners and alternate sites of care worldwide. The company has a market capitalization of $9.5 billion and operates through Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. HSIC is expected to release its Q3 2026 earnings soon.
Ahead of the event, analysts expect the company’s EPS to be $1.34 on a diluted basis, down 2.9% from $1.38 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters, which is impressive.